Multiparametric resonance and prostate fusion biopsy

The best imaging technique to locate malignant lesions and the best technique to ensure that the prostate biopsy is only performed on suspicious lesions and not unnecessarily.
This treatment marks an end to frequent biopsies which were often conducted at random.


Thanks to multiparametric nuclear resonance of the prostate, patients with prostate cancer can be studied with much greater precision, and it is even possible to predict whether the tumour is within or has already exceeded its limits.

Multiparametric nuclear resonance can select those cases in which biopsy can be avoided; and if this is necessary, only the suspicious area can be biopsied, avoiding so many punctures.

It is an incredible tool that is revolutionising diagnosis and changing therapeutic attitudes and monitoring of prostate cancer. What this means for the patient: less inconvenience.

When should this technique be used?

In most health centres, it tends to be recommended for patients who require a second or third biopsy. Using this technique, the medical team can carry out the most expert diagnostic examination meaning that cutting is only necessary if an area causes particular concern.

However, recent studies have also raised the following question: why leave the resonance for so late on in the patient journey? If we use it from the first possible moment, we can avoid a quarter of unnecessary biopsies, increase the detection of clinically significant cancers and reduce the diagnosis of clinically irrelevant cancers (cancers that, although present in the body, are not life-threatening). Currently, clinical practice guidelines recommend conducting a resonance before considering a biopsy.